Advance 13.0 August 9th 2025 

Presentations included:

 

Mast Cell Disease; an Overlooked Entity. – Hany Meawad, MD

 

Changes to Current Biomarker Testing and Emerging Biomarkers Based on Clinical Trials and Recent FDA Approvals – Sherri Z. Mills, PhD, MS, Astra Zeneca/Daiichi Sankyo, Inc.

 

IBD Related Dysplasia: A Practical Approach to Diagnosis - Roberto Alvaro A. Taguibao, MD

 

Portland and Our NEC of the Woods – Dustin Shackleton, MD